Pharmafit Provence
ESOXX ONE Oral gel Sachet unit/10ml

Alfasigma France

ESOXX ONE Oral gel Sachet unit/10ml

CIP / EAN code: 3401598593337

Product information from VIDAL.

Read the product information
Back to the catalogue

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Parapharmacy
Update of 03/12/2025

CE ESOXX® ONE

Forms and presentations 

Gel:  Single-dose sachet of 10 ml, box of 20 (ACL 3401598593337).

Composition 

Hyaluronic acid, chondroitin sulfate, polyvinylpyrrolidone, xylitol, sodium benzoate, potassium sorbate, grape flavouring, demineralised water, poloxamer 407.

PROPERTIES and USE 

Medical device recommended in cases of gastro-oesophageal reflux.

Gastro-oesophageal reflux (GOR) is characterised by symptoms (heartburn, acid regurgitation, irritative cough and dysphonia) that may or may not be associated with erosive inflammatory lesions of the oesophageal mucosa. Lying down generally aggravates GOR, which can therefore be more severe during the night.

Esoxx One is a combination of hyaluronic acid and chondroitin sulfate that protects the gastro-oesophageal mucosa through a mechanical action, rapidly reducing symptoms associated with gastro-oesophageal reflux: heartburn, epigastric pain, acid regurgitation, irritative cough and dysphonia.

The presence of a component with high bioadhesive capacity (poloxamer 407) in the Esoxx One formulation allows the hyaluronic acid - chondroitin sulfate combination to remain on the surface of the oesophageal wall, thereby contributing to the protective effect against the action of hydrochloric acid produced by the stomach.

Chondroitin sulfate also exerts an action that promotes the repair process of the gastro-oesophageal mucosa.

INSTRUCTIONS FOR USE 

One sachet (packaging corresponding to a single dose) after the main meals and before bedtime, or as recommended by a doctor.
Esoxx One can be drunk directly from the sachet.

Contraindications 

  • There are no specific contraindications, with the exception of hypersensitivity to any of the product's components. In this case, stop treatment and contact a doctor.
  • Despite the absence of any known adverse effects, this product must not be used during pregnancy or during the first months of breastfeeding. In all cases, it is advised to consult a doctor beforehand.

Precautions for use 

  • Do not exceed the recommended dose.
  • If symptoms persist, consult a doctor.
  • Due to the absence of clinical data in children under 12 years, do not use this product in children under 12 years.
  • Keep out of the reach of children.
Risk of interactions:
There are no known interactions with other products administered orally.

STORAGE CONDITIONS 

Store in a cool, dry place, away from any heat source. Do not freeze.
Do not use the product after the expiry date printed on the box.

ADMINISTRATIVE INFORMATION 

Medical device. CE marking 0477.
 
Manufacturer: Apharm SRL, Via Roma, 26, 28041 Arona, Italy.
Distributor: Alfasigma France.

ALFASIGMA FRANCE
Bords de Seine 1
3, esplanade du Foncet, 92130 Issy-les-Moulineaux
Tel: 01 45 21 02 69. Fax: 01 41 90 69 76
E-mail: info.fr@alfasigma.com

www.alfasigma.fr

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.